Stocks to buy: The Indian benchmark indices, Sensex and Nifty 50, snapped their three-day losing run on Monday, November 10, amid buying in IT and financial stocks and a positive trend in the global market.
The BSE Sensex ended the day at 319.07 points, or 0.38%, higher at 83,535. Meanwhile, the Nifty 50 settled the day 82.05 points, or 0.32 per cent, up at 25,574. During the day, the indices gained as much as 0.64%.
Except for the media index, which slipped 1%, all other sectoral indices ended in the green. The IT index gained 1.6%, supported by strong buying in Infosys, HCL Technologies, and Wipro. The pharma and metal indices also advanced nearly 1% and 0.6%, respectively.
Stock market today
Vaishali Parekh, Vice President of Technical Research at Prabhudas Lilladher, believes the index has taken support at the important 50-EMA level, and the market bias has improved, signalling a further upmove in the coming days.
Commenting on the key levels for Nifty 50, Parekh said, "Nifty, after taking support near the important 50EMA at 25320 zone, the index continued with the positive move to extend the gains and touched the 25650 zone during the intraday session to improve the bias, expecting further upward move in the coming days."
As mentioned earlier, the Nifty 50 index would need to move past the 25750 zone to establish conviction for a further rise towards targets of 26,100 and 26500, said the analyst. Meanwhile, the near-term support for Nifty remains at the 25300 zone, which needs to be sustained, she noted.
Vaishali Parekh's stock recommendations today
Regarding intraday stocks for today, Vaishali Parekh of Prabhudas Lilladher recommends three stocks to buy: Wockhardt, Gabriel India and Medico Remedies.
1. Wockhardt: Buy at ₹1,360 | Target at ₹1,450 | Stop loss at ₹1,320
2. Gabriel India: Buy at ₹1,255 | Target at ₹1,300 | Stop loss at ₹1,229
3. Medico Remedies: Buy at ₹51 | Target at ₹54 | Stop loss at ₹49
Disclaimer: This story is for educational purposes only. The views and recommendations expressed are those of individual analysts or broking firms, not Mint. We advise investors to consult with certified experts before making any investment decisions, as market conditions can change rapidly and circumstances may vary.
# Buy or Sell: Vaishali Parekh Recommends Three Stocks to Buy Today – November 11, 2025
November 11, 2025**
As Indian equities stage a tentative rebound amid global uncertainties, technical analyst Vaishali Parekh of Prabhudas Lilladher remains bullish on select pockets. With the Nifty 50 reclaiming key supports and eyeing fresh highs, Parekh's intraday picks focus on pharma, auto ancillaries, and smaller caps showing momentum. In her latest note, she flags three buys: Wockhardt, Gabriel India, and Medico Remedies—betting on their breakout potential in a risk-on environment. Let's unpack her rationale, targets, and the broader market setup.
## Market Outlook: Nifty and Bank Nifty Signal Upside Momentum
Parekh sees green shoots after recent volatility. The Nifty 50, having bounced from the crucial 50-EMA at 25,320, touched 25,650 intraday and closed with improved bias. A sustained move above 25,750 could unlock targets of 26,100 and 26,500, with near-term support at 25,300. For today, expect support at 25,450 and resistance at 25,800— a range favoring bulls if volumes hold.
Bank Nifty, up marginally, faces resistance at 58,000 but eyes a decisive break above 58,500 for a push to 60,000. Downside cushion lies at the 50-EMA of 56,500, with today's range pegged at 57,600-58,700. This setup aligns with broader optimism, as FIIs turn net buyers post-U.S. election clarity and domestic SIP flows cushion dips.
## Vaishali Parekh's Top Three Buys: Details and Strategy
Parekh's selections emphasize stocks with clean charts, positive volume spikes, and proximity to key moving averages—ideal for intraday trades in a consolidating market. No deep dives on individual catalysts, but her picks lean toward sectors like healthcare and autos rebounding from oversold levels. Here's the breakdown:
- **Wockhardt (Pharma Giant)**: Buy at ₹1,360 | Target: ₹1,450 | Stop Loss: ₹1,320
Parekh spots upward momentum in this API player, potentially riding sector tailwinds from export demand. A 6.6% upside to target offers quick gains if Nifty holds supports.
- **Gabriel India (Auto Ancillary)**: Buy at ₹1,255 | Target: ₹1,300 | Stop Loss: ₹1,229
With auto stocks perking up on festive recovery signals, this shock absorber maker shows strength above its 20-DEMA. Risk-reward tilts positive at 3.6% potential, tight SL for protection.
- **Medico Remedies (Small-Cap Pharma)**: Buy at ₹51 | Target: ₹54 | Stop Loss: ₹49
A speculative bet on this formulations firm, eyeing volume-led breakout. Modest 5.9% target suits scalpers, with low entry making it accessible amid broader small-cap rotation.
| Stock | Buy Price (₹) | Target (₹) | Stop Loss (₹) | Potential Upside (%) | Sector |
|-------|---------------|------------|---------------|----------------------|--------|
| Wockhardt | 1,360 | 1,450 | 1,320 | 6.6% | Pharmaceuticals |
| Gabriel India | 1,255 | 1,300 | 1,229 | 3.6% | Auto Ancillaries |
| Medico Remedies | 51 | 54 | 49 | 5.9% | Pharmaceuticals |
*Note: These are intraday calls; always factor in real-time charts and risk 1-2% of capital per trade.*
## Investor Takeaway: Momentum Trades in a Bullish Tilt
Parekh's playbook underscores discipline: Enter on pullbacks, trail stops, and exit at targets to lock profits. With Nifty's EMA support intact, these picks could shine if global cues (like softer U.S. yields) cooperate. However, watch for profit-booking near resistances—volatility remains a wildcard post-Diwali.
Scaling into SIPs or hedging with puts? These intraday ideas complement long-term holds. What's your play today—diving into pharma or sticking to indices? Comment below.
No comments:
Post a Comment